Page last updated: 2024-10-25

desipramine and Atherosclerotic Parkinsonism

desipramine has been researched along with Atherosclerotic Parkinsonism in 3 studies

Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Woodgate, A1
MacGibbon, G1
Walton, M1
Dragunow, M1
el-Awar, M1
Freedman, M1
Seeman, P1
Goldenberg, L1
Little, J1
Solomon, P1
Snyder, AM1
Stricker, EM1
Zigmond, MJ1

Other Studies

3 other studies available for desipramine and Atherosclerotic Parkinsonism

ArticleYear
The toxicity of 6-hydroxydopamine on PC12 and P19 cells.
    Brain research. Molecular brain research, 1999, May-21, Volume: 69, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Aurintricarboxylic Acid; Biological Transport; Bisbenzimi

1999
Response of tardive and L-dopa-induced dyskinesias to antidepressants.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1987, Volume: 14, Issue:4

    Topics: Aged; Antidepressive Agents; Depressive Disorder; Desipramine; Dyskinesia, Drug-Induced; Humans; Lev

1987
Stress-induced neurological impairments in an animal model of parkinsonism.
    Annals of neurology, 1985, Volume: 18, Issue:5

    Topics: Animals; Bupropion; Corpus Striatum; Deoxyglucose; Desipramine; Dopamine; Dose-Response Relationship

1985